Edges in Network
Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | MYL9 |
Upstream (Parents) |
---|
(<<) ADAM12 → MYL9 |
(<<) CAV1 → MYL9 |
(<<) CDH11 → MYL9 |
(<<) IGFBP4 → MYL9 |
(<<) IGFBP7 → MYL9 |
(<<) MMP2 → MYL9 |
(<<) THY1 → MYL9 |
Downstream (Children) |
---|
MYL9 → ACTA2 (>>) |
MYL9 → ACTN1 (>>) |
MYL9 → AKAP12 (>>) |
MYL9 → AKT3 (>>) |
MYL9 → ANGPTL4 (>>) |
MYL9 → ATP2A2 (>>) |
MYL9 → BMP1 (>>) |
MYL9 → CHST3 (>>) |
MYL9 → CLDN5 (>>) |
MYL9 → CREB3 (>>) |
MYL9 → CREB3L1 (>>) |
MYL9 → CRYAB (>>) |
MYL9 → CTGF (>>) |
MYL9 → CXCL14 (>>) |
MYL9 → CYR61 (>>) |
MYL9 → DDIT3 (>>) |
MYL9 → EDN1 (>>) |
MYL9 → EFEMP1 (>>) |
MYL9 → EFEMP2 (>>) |
MYL9 → FGF1 (>>) |
MYL9 → IGFBP3 (>>) |
MYL9 → INHBA (>>) |
MYL9 → ISLR (>>) |
MYL9 → ITGA7 (>>) |
MYL9 → JAG1 (>>) |
MYL9 → KRT14 (>>) |
MYL9 → KRT5 (>>) |
MYL9 → MAPK13 (>>) |
MYL9 → MXRA8 (>>) |
MYL9 → MYLK (>>) |
MYL9 → NBL1 (>>) |
MYL9 → NNMT (>>) |
MYL9 → NRN1 (>>) |
MYL9 → PPAP2A (>>) |
MYL9 → PRKCDBP (>>) |
MYL9 → PTRF (>>) |
MYL9 → RECK (>>) |
MYL9 → RRAS (>>) |
MYL9 → SMTN (>>) |
MYL9 → STK17A (>>) |
MYL9 → SULF1 (>>) |
MYL9 → THBS1 (>>) |
MYL9 → TIMP1 (>>) |
MYL9 → TIMP3 (>>) |
MYL9 → TNC (>>) |
MYL9 → TPM1 (>>) |
MYL9 → TPM2 (>>) |
MYL9 → YRDC (>>) |